PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and cent…
Thyroid Eye Disease (TED) Treatments Market Nears $4.3 Billion by 2032: Emerging Small Molecule Therapies Targeting Orbital Fibroblasts Drive Revenue Growth – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Thyroid Eye Disease Treatments Market – Global Forecast 2025-2032” report has been added to ResearchAndMarkets.com’s offering. The thyroid eye disease treatments market is undergoing substantial transformation, fueled by n…
Broadwood Partners Denounces STAAR Surgical’s Fourth Delay of the Shareholder Vote on the Company’s Proposed Sale to Alcon
NEW YORK–(BUSINESS WIRE)–Broadwood Partners, L.P. and its affiliates (“Broadwood” or “we”), which together own 30.2% of the outstanding common stock of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA), today responded to the fourth po…
Alcon Exercises Right to Require STAAR Surgical to Adjourn its Special Meeting of Stockholders
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), the manufacturer of the Implantable Collamer® Lens (ICL) today announced that Alcon (SIX/NYSE: ALC) has exercised its right under the Alcon merger agreement to require STAAR t…
Man presents with chronic dull pain in left eye
A 63-year-old Vietnamese-speaking man with a history of scleritis in the left eye, epiretinal membrane, dry eye syndrome and age-related cataracts presented to the retina clinic for a follow-up on a chronic blind, painful left eye.The patient had a lon…
TFOS DEWS III offers latest on dry eye disease
Eye care practitioners have a wealth of new information to inform their handling of dry eye disease with the third iteration of the Tear Film & Ocular Surface Society Dry Eye Workshop report.“Everybody does dry eye differently,” Fiona Stapleton, FCOpto…